We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Trial Drug Blocks Early Stages of COVID-19 in Engineered Human Tissues

News   Apr 03, 2020 | Original story from the University of British Columbia

 
Trial Drug Blocks Early Stages of COVID-19 in Engineered Human Tissues

Credit: IMBA - Tibor Kulcsar

 
 
Advertisement
 

RELATED ARTICLES

Evidence That Protocells Could Have Made Specialized Compartments

News

New research by the University of Oslo provides evidence that the protocells that formed around 3.8 billion years ago, before bacteria and single-celled organisms, could have had specialized bubble-like compartments that formed spontaneously, encapsulated small molecules, and formed "daughter" protocells.

READ MORE

Data Shows Pfizer-BioNTech COVID-19 Vaccine Provides Protection From First Dose

News

An independent analysis conducted by Public Health England (PHE) in the UK demonstrates that the Pfizer-BioNTech COVID-19 vaccine BNT162b2 provides protection against infection and asymptomatic disease after the first dose.

READ MORE

Two New Rapid COVID-19 Diagnostic Tests Developed

News

University of Minnesota Medical School researchers have developed two new rapid diagnostic tests for COVID-19 - one to detect COVID-19 variants and one to help differentiate with other illnesses that have COVID-19-like symptoms.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE